Publicaciones en colaboración con investigadores/as de King's College London (446)

2024

  1. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort

    Schizophrenia Research, Vol. 266, pp. 237-248

  2. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

    Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512

  3. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  4. Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

    Schizophrenia Bulletin, Vol. 50, Núm. 2, pp. 327-338

  5. Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression – Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis

    Journal of Affective Disorders, Vol. 361, pp. 674-683

  6. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis

    Health technology assessment (Winchester, England), Vol. 28, Núm. 47, pp. 1-119

  7. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

  8. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

    The Lancet Regional Health - Europe, Vol. 38

  9. Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

    Psychological Medicine, Vol. 54, Núm. 7, pp. 1339-1349

  10. Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

    Blood, Vol. 143, Núm. 17, pp. 1713-1725

  11. Duration of Untreated Psychosis and Outcomes in First-Episode Psychosis: Systematic Review and Meta-analysis of Early Detection and Intervention Strategies

    Schizophrenia Bulletin, Vol. 50, Núm. 4, pp. 771-783

  12. Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy

    Journal of Autism and Developmental Disorders, Vol. 54, Núm. 7, pp. 2733-2741

  13. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  14. Finding the Right Setting for the Right Treatment During the Acute Treatment of Individuals with Schizophrenia: A Narrative Review and Clinical Practice Guideline

    Neuropsychiatric Disease and Treatment, Vol. 20, pp. 1293-1307

  15. Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study

    Psychiatry Research, Vol. 342

  16. IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management—an International Delphi Study

    Obesity Surgery, Vol. 34, Núm. 1, pp. 30-42

  17. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia

    European Neuropsychopharmacology, Vol. 82, pp. 57-71

  18. Influence of Pathophysiologic Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes

    Circulation, Vol. 150, Núm. 8, pp. 586-597

  19. Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents

    Human Brain Mapping, Vol. 45, Núm. 11